Table 3.
Chest computed tomography scan characteristics of 34 patients with hypoxemic pneumonia due to COVID-19.
| Co-infection | ||||
| Characteristics | Total (n = 34) | No (n = 30) | Yes (n = 4) | P value |
| Time from onset of symptoms | ||||
| Pulmonary infiltrates, n (%) | 34 (100) | 30 (100) | 4 (100) | .96 |
| Bilateral involvment, n (%) | 33 (97.1) | 29 (96.7) | 4 (100) | .99 |
| Extension of pulmonary infiltrates: | .58 | |||
| -stage 0: none, n (%) | 0 | 0 | 0 | |
| - stage 1: low (<10%), n (%) | 0 | 0 | 0 | |
| - stage 2: moderate (10 to 25%), n (%) | 18 (52.9) | 16 (53.3) | 2 (50) | |
| - stage 3: extended (25 to 50%), n (%) | 7 (20.6) | 6 (20) | 1 (25) | |
| - stage 4: severe (50 to 75%), n (%) | 9 (26.5) | 8 (26.7) | 1 (25) | |
| - stage 5: critical (>75%), n (%) | 0 | 0 | 0 | |
| Ground glass opacities, n (%) | 33 (97.1) | 29 (96.7) | 4 (100) | .97 |
| Consolidations, n (%) | 27 (79.4) | 24 (80) | 3 (75) | .62 |
| Crazy paving, n (%) | 19 (55.9) | 17 (56.7) | 2 (50) | .6 |
| Pleural effusion, n (%) | 6 (17.6) | 5 (16.7) | 1 (25) | .56 |
Results are expressed at n (%) or median [25th–75th].
Thirty-four of the 36 patients with COVID-19 pneumonia underwent a chest computed tomography scan.